Literature DB >> 1783617

Purification and partial characterization of alpha-N-acetylglucosaminidase from human liver.

T Sasaki1, K Sukegawa, M Masue, S Fukuda, S Tomatsu, T Orii.   

Abstract

A deficiency in alpha-N-acetylglucosaminidase is known as mucopolysaccharidosis IIIB or Sanfilippo B syndrome. We purified this enzyme almost 39,000-fold from liver to homogeneity with 3% recovery. Use of concanavalin A (Con A)-Sepharose and heparin-Sepharose resulted in 13.4-fold and 11.6-fold purifications of the enzymatic activity, respectively. The molecular mass was estimated to be 300 kDa by gel filtration and 80 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. The isoelectric point was 5.1, optimal pH was 4.5, and the Km for p-nitrophenyl alpha-N-acetylglucosamine was 0.13-0.20 mM. The purified enzyme was stable at 50 degrees C for 1 h and within the pH range of 6.5-8.5. Anti-serum against the purified enzyme raised in BALB/c mice inhibited the activities of alpha-N-acetylglucosaminidase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1783617     DOI: 10.1093/oxfordjournals.jbchem.a123668

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  The molecular basis of Sanfilippo syndrome type B.

Authors:  H G Zhao; H H Li; G Bach; A Schmidtchen; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer.

Authors:  Guglielmo R D Villani; Antonia Follenzi; Borghina Vanacore; Carmela Di Domenico; Luigi Naldini; Paola Di Natale
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

3.  Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts.

Authors:  Shih-hsin Kan; Larisa A Troitskaya; Carolyn S Sinow; Karyn Haitz; Amanda K Todd; Ariana Di Stefano; Steven Q Le; Patricia I Dickson; Brigette L Tippin
Journal:  Biochem J       Date:  2014-03-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.